14th Annual Conference on Statistical Issues in Clinical Trials: Subgroup Analysis

MORNING SESSION

David Kent, MD (Tufts University)

Overview: Overall average treatment effects and one-variable-at-a-time subgroup analysis: The Scylla and Charybdis of Evidence Based Medicine

Ellis Unger, MD (Consultant)

An "unofficial" US Regulatory Perspective

Tom Fleming, PhD (University of Washington)

Pitfalls of subgroup analysis

Lisa McShane, PhD (NCI) 

Finding the subgroup of patients who benefit from a novel therapy: no time for a game of hide and seek

AFTERNOON SESSION

Noah Simon, PhD (University of Washington)

Adaptive Enrichment Trials: Identifying the 'right' subgroup

Anastasia Ivanova, PhD (UNC)

Antimicrobial prophylaxis for vesicoureteral reflux: which children benefit the most?

Ilya Lipkovich, PhD (Eli Lilly)

Comparison of recent approaches for subgroup identification from clinical and observational data

Patrick Schnell, PhD (Ohio State)

Multiplicity considerations for analyses of non-exchangeable subgroups

PANELISTS

Mark Rothmann (FDA)
Kosuke Imai (Harvard)
Kit Roes (European Regulatory Perspective)
Michael Rosenblum (Johns Hopkins)
Janet Wittes (Statistics Collaborative, Inc.)